Clinical characteristics of non ‐small cell lung cancer patients with EGFR mutations and ALK & ROS1 fusions

ConclusionsEGFR mutations were more likely to occur in non-smoking, stage III –IV, and female patients with lung adenocarcinoma, whereasALK&ROS1 gene fusions were more likely to occur in young patients with lung adenocarcinoma. Emphysema was less common in patients withEGFR mutations.

Source: The Clinical Respiratory Journal - January 26, 2022 Category: Respiratory Medicine Authors: Qinghua Liu, Qingyan Huang, Zhikang Yu, Heming Wu Tags: ORIGINAL ARTICLE Source Type: research